Aja-Macaya, Pablo
Rumbo-Feal, Soraya
Poza, Margarita
Cañizares, Angelina
Vallejo, Juan A.
Bou, Germán
Funding for this research was provided by:
SERGAS-Galician Healthcare Service (Innova Saúde, Innova Saúde, Innova Saúde, Innova Saúde)
Instituto de Salud Carlos III (CIBERINFEC, PI20/00413, CIBERINFEC)
Article History
Received: 28 July 2022
Accepted: 4 January 2023
First Online: 17 January 2023
Declarations
:
: In order to satisfy any ethical or legal consideration, the study was carried out adhering to the standards of good clinical practice and current research regulations included in Law of Biomedical Research 14/2007, in accordance with the principles derived from the latest version of the Declaration of Helsinki and of the Convention on Human Rights and Biomedicine (the Oviedo Convention). Compliance with the protection of personal data of all those involved in the Organic Law 15/1999 and its implementing regulations, Royal Decree 1720/2007, is enforced. Sample names have been anonymized. Additionally, the research ethics committee, named “Comité de Ética de la Investigación de A Coruña - Ferrol”, states that this study does not require neither ethical oversight nor the patients’ informed consent. Also the informed consent was waived off by the the research ethics committee, named “Comité de Ética de la Investigación de A Coruña - Ferrol”. The obtained information comes from pathogenic organisms, not from the patients’ clinical data and is not considered as belonging to them but to the pathogen. Neither the Spanish legislation for data protection and biomedical investigation, nor the European one, indicate that this study has to go through the revision of an ethics committee.
: Not applicable.
: The authors declare that they have no competing interests.